Risks with Cytoreductive TherapyVideo Categories: Polycythemia Vera
Supported through funding from Incyte
According to Alexander Bastian, it’s very difficult to determine how to integrate cost into the equation of cancer care. He explains that cost should be considered early on and uses Dr. Zafar’s term of financial toxicity, meaning the burden of cost can be as bad or worse than a physical [ Read More ]
Gary Palmer, MD, discusses the importance of patients knowing the DNA drivers of their cancer to slow the growth of their cancer.